Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria

Pediatr Allergy Immunol. 2018 Jun;29(4):449-450. doi: 10.1111/pai.12877. Epub 2018 Apr 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Allergic Agents / adverse effects*
  • Anti-Allergic Agents / therapeutic use
  • Child
  • Chronic Disease
  • Female
  • Humans
  • Omalizumab / adverse effects*
  • Omalizumab / therapeutic use
  • Serum Sickness / chemically induced*
  • Serum Sickness / diagnosis
  • Urticaria / drug therapy*

Substances

  • Anti-Allergic Agents
  • Omalizumab